FDA Panel Recommends mRNA Flu Vaccine for Older Adults

FDA panel recommends mRNA flu vaccine for older adults

Currently, the FDA has no permanent vaccine chief nor a commissioner, so it’s not clear who will make the final decision on Moderna’s flu shot.

FDA Committee OK’s Moderna mRNA-1010 Influenza Shot with Less Than 1% Absolute Benefit, Clears the Way for FDA Approval

by Jon Fleetwood, Jon Fleetwood: VRBPAC members revealed: a former Moderna advisory board member, current GlaxoSmithKline and Merck executives, federal and university figures whose careers depend on vaccines. The Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted unanimously on Thursday that the “benefits” of Moderna’s experimental mRNA influenza vaccine, mFlusiva (mRNA-1010), “outweigh […]

One Historic Week for Flu: Generic Xofluza Approved June 17, mRNA Flu Vaccine VRBPAC Vote June 18 — Here's What Both Mean for 2026–27

FDA approved generic baloxavir June 17; VRBPAC voted on mRNA flu vaccine June 18. The 2025–26 flu season killed 24,000 Americans. Here's what both mean for 2026–27.

FDA panel considers a first-of-its-kind flu vaccine using mRNA technology

WASHINGTON (AP) — U.S. health advisers are debating a new kind of flu vaccine Thursday, the first made with the same mRNA technology that was key to ending the COVID-19 pandemic.